Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

TEAG Forum: NCI Drug Development Resources: PREVENT and NExT Programs

Date: Monday, February 13, 2023
Time: 11:00am EST to 12:00pm EST

TEAG encourages the exchange of information across NCI by coordinating forums to foster interdisciplinary research and collaborations. This forum will highlight two NCI programs designed to support preclinical development of innovative strategies for cancer prevention, through the PREVENT program, and cancer treatment, through the NCI Experimental Therapeutics (NExT) program. These are not grant programs, but rather allocate NCI contract resources and expertise to generate data and materials, which are used by the awardees for further development.

Speakers

Mark Steven Miller, Ph.D.
Deputy Chief / Program Director
Chemopreventive Agent Development
Director of PREVENT Operations
NCI Division of Cancer Prevention (DCP)
Email: mark.miller5@nih.gov

John Giraldes
Program Manager
NCI Experimental Therapeutics (NExT) Program
NCI Division of Cancer Treatment and Diagnosis (DCTD)
Email: john.giraldes@nih.gov